173 related articles for article (PubMed ID: 30292066)
1. Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33.
Tantravedi S; Vesuna F; Winnard PT; Martin A; Lim M; Eberhart CG; Berlinicke C; Raabe E; van Diest PJ; Raman V
Transl Oncol; 2019 Jan; 12(1):96-105. PubMed ID: 30292066
[TBL] [Abstract][Full Text] [Related]
2. Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer.
Heerma van Voss MR; Vesuna F; Trumpi K; Brilliant J; Berlinicke C; de Leng W; Kranenburg O; Offerhaus GJ; Bürger H; van der Wall E; van Diest PJ; Raman V
Oncotarget; 2015 Sep; 6(29):28312-26. PubMed ID: 26311743
[TBL] [Abstract][Full Text] [Related]
3. RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3.
Xie M; Vesuna F; Tantravedi S; Bol GM; Heerma van Voss MR; Nugent K; Malek R; Gabrielson K; van Diest PJ; Tran PT; Raman V
Cancer Res; 2016 Nov; 76(21):6340-6350. PubMed ID: 27634756
[TBL] [Abstract][Full Text] [Related]
4. Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.
Bol GM; Vesuna F; Xie M; Zeng J; Aziz K; Gandhi N; Levine A; Irving A; Korz D; Tantravedi S; Heerma van Voss MR; Gabrielson K; Bordt EA; Polster BM; Cope L; van der Groep P; Kondaskar A; Rudek MA; Hosmane RS; van der Wall E; van Diest PJ; Tran PT; Raman V
EMBO Mol Med; 2015 May; 7(5):648-69. PubMed ID: 25820276
[TBL] [Abstract][Full Text] [Related]
5. RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma.
Wilky BA; Kim C; McCarty G; Montgomery EA; Kammers K; DeVine LR; Cole RN; Raman V; Loeb DM
Oncogene; 2016 May; 35(20):2574-83. PubMed ID: 26364611
[TBL] [Abstract][Full Text] [Related]
6. Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment.
Heerma van Voss MR; Vesuna F; Bol GM; Afzal J; Tantravedi S; Bergman Y; Kammers K; Lehar M; Malek R; Ballew M; Ter Hoeve N; Abou D; Thorek D; Berlinicke C; Yazdankhah M; Sinha D; Le A; Abrahams R; Tran PT; van Diest PJ; Raman V
Oncogene; 2018 Jan; 37(1):63-74. PubMed ID: 28869602
[TBL] [Abstract][Full Text] [Related]
7. Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth.
Baryawno N; Sveinbjörnsson B; Eksborg S; Chen CS; Kogner P; Johnsen JI
Cancer Res; 2010 Jan; 70(1):266-76. PubMed ID: 20028853
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
Koch A; Hrychyk A; Hartmann W; Waha A; Mikeska T; Waha A; Schüller U; Sörensen N; Berthold F; Goodyer CG; Wiestler OD; Birchmeier W; Behrens J; Pietsch T
Int J Cancer; 2007 Jul; 121(2):284-91. PubMed ID: 17373666
[TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress.
Oh S; Flynn RA; Floor SN; Purzner J; Martin L; Do BT; Schubert S; Vaka D; Morrissy S; Li Y; Kool M; Hovestadt V; Jones DT; Northcott PA; Risch T; Warnatz HJ; Yaspo ML; Adams CM; Leib RD; Breese M; Marra MA; Malkin D; Lichter P; Doudna JA; Pfister SM; Taylor MD; Chang HY; Cho YJ
Oncotarget; 2016 May; 7(19):28169-82. PubMed ID: 27058758
[TBL] [Abstract][Full Text] [Related]
10. Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach.
Heerma van Voss MR; Kammers K; Vesuna F; Brilliant J; Bergman Y; Tantravedi S; Wu X; Cole RN; Holland A; van Diest PJ; Raman V
Transl Oncol; 2018 Jun; 11(3):755-763. PubMed ID: 29684792
[TBL] [Abstract][Full Text] [Related]
11. RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2.
Vesuna F; Akhrymuk I; Smith A; Winnard PT; Lin SC; Panny L; Scharpf R; Kehn-Hall K; Raman V
Front Microbiol; 2022; 13():959577. PubMed ID: 36090095
[TBL] [Abstract][Full Text] [Related]
12. Role of DDX3 in the pathogenesis of inflammatory bowel disease.
Tantravedi S; Vesuna F; Winnard PT; Van Voss MRH; Van Diest PJ; Raman V
Oncotarget; 2017 Dec; 8(70):115280-115289. PubMed ID: 29383159
[TBL] [Abstract][Full Text] [Related]
13. Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.
Bassani B; Bartolini D; Pagani A; Principi E; Zollo M; Noonan DM; Albini A; Bruno A
PLoS One; 2016; 11(7):e0154111. PubMed ID: 27367907
[TBL] [Abstract][Full Text] [Related]
14. Biflavone Ginkgetin, a Novel Wnt Inhibitor, Suppresses the Growth of Medulloblastoma.
Ye ZN; Yu MY; Kong LM; Wang WH; Yang YF; Liu JQ; Qiu MH; Li Y
Nat Prod Bioprospect; 2015 Mar; 5(2):91-7. PubMed ID: 25821199
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization.
Bhatia S; Baig NA; Timofeeva O; Pasquale EB; Hirsch K; MacDonald TJ; Dritschilo A; Lee YC; Henkemeyer M; Rood B; Jung M; Wang XJ; Kool M; Rodriguez O; Albanese C; Karam SD
Oncotarget; 2015 Apr; 6(11):8929-46. PubMed ID: 25879388
[TBL] [Abstract][Full Text] [Related]
16. SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling.
Li C; Li H; Zhang P; Yu LJ; Huang TM; Song X; Kong QY; Dong JL; Li PN; Liu J
Nutrients; 2016 Dec; 9(1):. PubMed ID: 28035977
[TBL] [Abstract][Full Text] [Related]
17. miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1.
Li KK; Pang JC; Ching AK; Wong CK; Kong X; Wang Y; Zhou L; Chen Z; Ng HK
Hum Pathol; 2009 Sep; 40(9):1234-43. PubMed ID: 19427019
[TBL] [Abstract][Full Text] [Related]
18. RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2.
Vesuna F; Akhrymuk I; Smith A; Winnard PT; Lin SC; Scharpf R; Kehn-Hall K; Raman V
bioRxiv; 2022 Mar; ():. PubMed ID: 35262079
[TBL] [Abstract][Full Text] [Related]
19. ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma.
Ingram WJ; Crowther LM; Little EB; Freeman R; Harliwong I; Veleva D; Hassall TE; Remke M; Taylor MD; Hallahan AR
Exp Hematol Oncol; 2013 Oct; 2(1):26. PubMed ID: 24219920
[TBL] [Abstract][Full Text] [Related]
20. Integrated Proteomic and Transcriptomic-Based Approaches to Identifying Signature Biomarkers and Pathways for Elucidation of Daoy and UW228 Subtypes.
Higdon R; Kala J; Wilkins D; Yan JF; Sethi MK; Lin L; Liu S; Montague E; Janko I; Choiniere J; Kolker N; Hancock WS; Kolker E; Fanayan S
Proteomes; 2017 Feb; 5(1):. PubMed ID: 28248256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
